Literature DB >> 7513309

A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.

A Sadziene1, M Jonsson, S Bergström, R K Bright, R C Kennedy, A G Barbour.   

Abstract

Borrelia burgdorferi, an agent of Lyme disease, is killed by some monoclonal antibodies in the absence of complement or phagocytes. In the present study, the bactericidal action of monoclonal antibodies against B. burgdorferi and B. hermsii, a cause of relapsing fever, was further characterized. H6831, an antibody recognizing the OspB proteins of some B. burgdorferi strains, and H4825, an antibody specific for one serotype of B. hermsii, were purified, and Fab fragments of the antibodies were prepared. In time-kill studies, more than 99.9% of strain B31 B. burgdorferi cells were killed after 30 min of exposure to H6831 Fab fragments. The MBC of the Fab fragments was 10 micrograms/ml. Electron microscopy revealed that the bactericidal Fab fragments produced numerous blebs and cell lysis of the borrelias for which they were specific. To identify the epitope for H6831, the OspB sequences of H6831-susceptible and -resistant strains and mutants were determined. The deduced OspB proteins of all H6831-resistant strains and mutants differed from the strain B31 OspB at residue 253. Murine antisera raised against a 21-mer synthetic peptide representing the region around residue 253 were specific for strain B31 by Western blot (immunoblot) and growth inhibition assays. Furthermore, the antipeptide serum inhibited the binding of H6831 to whole borrelias. These findings indicated that the linear component of the bactericidal antibody's epitope was located at or near residue 253.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513309      PMCID: PMC186463          DOI: 10.1128/iai.62.5.2037-2045.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Authors:  J L Schmitz; R F Schell; S D Lovrich; S M Callister; J E Coe
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

3.  Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.

Authors:  M E Brandt; B S Riley; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

4.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization.

Authors:  A Sadziene; D D Thomas; V G Bundoc; S C Holt; A G Barbour
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 6.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 7.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

8.  Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.

Authors:  E Fikrig; S W Barthold; N Marcantonio; K Deponte; F S Kantor; R A Flavell
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi.

Authors:  S Bergström; V G Bundoc; A G Barbour
Journal:  Mol Microbiol       Date:  1989-04       Impact factor: 3.501

10.  Antiborrelial activity of serum from rats injected with the Lyme disease spirochete.

Authors:  C S Pavia; V Kissel; S Bittker; F Cabello; S Levine
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  31 in total

1.  In vitro assessment of antiborrelial activity of OspA vaccine sera.

Authors:  Paul T Fawcett; Carlos D Rose; Kathleen M Gibney
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Pathogen-specific antibodies: codependent no longer.

Authors:  Edward N Janoff; Daniel N Frank
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

3.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

4.  Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

Authors:  S M Callister; D A Jobe; R F Schell; C S Pavia; S D Lovrich
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

5.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

6.  Bacterial lipoproteins can disseminate from the periphery to inflame the brain.

Authors:  Diana Londoño; Diego Cadavid
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

7.  Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.

Authors:  Gabrielle Richard; C Roger MacKenzie; Kevin A Henry; Evgeny Vinogradov; J Christopher Hall; Greg Hussack
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

8.  Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).

Authors:  K Kurtenbach; A Dizij; H M Seitz; G Margos; S E Moter; M D Kramer; R Wallich; U E Schaible; M M Simon
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Changes in bacterial growth rate govern expression of the Borrelia burgdorferi OspC and Erp infection-associated surface proteins.

Authors:  Brandon L Jutras; Alicia M Chenail; Brian Stevenson
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

Review 10.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.